Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 4
2002 2
2003 1
2004 1
2005 1
2006 1
2007 3
2013 1
2014 5
2015 3
2016 2
2017 2
2018 3
2019 2
2021 3
2022 1
2023 2
2024 1
2025 1
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Comparative theranostic efficacy of 177Lu- and 161Tb-labeled A1K2 SdAb in mesothelin-positive tumors.
N'Guessan É, Raes F, Ahmadi M, Bacot S, Dumas L, Leenhardt J, du Moulinet d'Hardemare A, Debiossat M, André C, Boutonnat J, Durivault J, Montemagno C, Lenormand JL, Djaïleb L, Köster U, Van de Voorde M, Ramaekers S, Verguts K, Ghezzi C, Perret P, Lombardi C, Broisat A. N'Guessan É, et al. Among authors: ghezzi c, perret p. Eur J Nucl Med Mol Imaging. 2026 May;53(6):3775-3788. doi: 10.1007/s00259-025-07723-z. Epub 2025 Dec 27. Eur J Nucl Med Mol Imaging. 2026. PMID: 41454065 Free PMC article.
Role of Cardiac AMP-Activated Protein Kinase in a Non-pathological Setting: Evidence From Cardiomyocyte-Specific, Inducible AMP-Activated Protein Kinase α1α2-Knockout Mice.
Tokarska-Schlattner M, Kay L, Perret P, Isola R, Attia S, Lamarche F, Tellier C, Cottet-Rousselle C, Uneisi A, Hininger-Favier I, Foretz M, Dubouchaud H, Ghezzi C, Zuppinger C, Viollet B, Schlattner U. Tokarska-Schlattner M, et al. Among authors: ghezzi c, perret p. Front Cell Dev Biol. 2021 Oct 18;9:731015. doi: 10.3389/fcell.2021.731015. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34733845 Free PMC article.
Molecular imaging of liver inflammation using an anti-VCAM-1 nanobody.
Nachit M, Montemagno C, Clerc R, Ahmadi M, Briand F, Bacot S, Devoogdt N, Serdjebi C, Ghezzi C, Sulpice T, Broisat A, Leclercq IA, Perret P. Nachit M, et al. Among authors: ghezzi c, perret p. Nat Commun. 2023 Feb 24;14(1):1062. doi: 10.1038/s41467-023-36776-7. Nat Commun. 2023. PMID: 36828835 Free PMC article.
Biodistribution and preliminary toxicity studies of nanoparticles made of Biotransesterified β-cyclodextrins and PEGylated phospholipids.
Perret P, Bacot S, Gèze A, Gentil Dit Maurin A, Debiossat M, Soubies A, Blanc-Marquis V, Choisnard L, Boutonnat J, Ghezzi C, Putaux JL, Lancelon-Pin C, Riou LM, Wouessidjewe D. Perret P, et al. Among authors: ghezzi c. Mater Sci Eng C Mater Biol Appl. 2018 Apr 1;85:7-17. doi: 10.1016/j.msec.2017.12.017. Epub 2017 Dec 15. Mater Sci Eng C Mater Biol Appl. 2018. PMID: 29407159
Preclinical and clinical evaluation of a new method to assess cardiac insulin resistance using nuclear imaging.
Perret P, Slimani L, Barone-Rochette G, Vollaire J, Briat A, Ahmadi M, Henri M, Desruet MD, Clerc R, Broisat A, Riou L, Boucher F, Frouin F, Djaileb L, Calizzano A, Vanzetto G, Fagret D, Ghezzi C. Perret P, et al. Among authors: ghezzi c. J Nucl Cardiol. 2022 Jun;29(3):1419-1429. doi: 10.1007/s12350-020-02520-7. Epub 2021 Jan 27. J Nucl Cardiol. 2022. PMID: 33502690
This study aimed to introduce a new method using (123)I-6-deoxy-6-iodo-D-glucose (6DIG), a pure tracer of glucose transport, for the assessment of IR using cardiac dynamic nuclear imaging. ...
This study aimed to introduce a new method using (123)I-6-deoxy-6-iodo-D-glucose (6DIG), a pure tracer of glucose transport, f …
TrisOxine abiotic siderophores for technetium complexation: radiolabeling and biodistribution studies.
Leenhardt J, Biguet Petit Jean A, Raes F, N'Guessan E, Debiossat M, André C, Bacot S, Ahmadi M, de Leiris N, Djaileb L, Ghezzi C, Brunet MD, Broisat A, Perret P, du Moulinet d'Hardemare A. Leenhardt J, et al. Among authors: ghezzi c, perret p. EJNMMI Radiopharm Chem. 2023 Oct 19;8(1):32. doi: 10.1186/s41181-023-00214-2. EJNMMI Radiopharm Chem. 2023. PMID: 37856008 Free PMC article.
Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4.
Kim JK, Zisman A, Fillmore JJ, Peroni OD, Kotani K, Perret P, Zong H, Dong J, Kahn CR, Kahn BB, Shulman GI. Kim JK, et al. Among authors: perret p. J Clin Invest. 2001 Jul;108(1):153-60. doi: 10.1172/JCI10294. J Clin Invest. 2001. PMID: 11435467 Free PMC article.
Using cre/loxP gene targeting, transgenic mice with muscle-specific inactivation of the GLUT4 gene (muscle GLUT4 KO) were generated and shown to develop a diabetes phenotype. To determine the mechanism, we examined insulin-stimulated glucose uptake and metabolism du …
Using cre/loxP gene targeting, transgenic mice with muscle-specific inactivation of the GLUT4 gene (muscle GLUT4 KO) were generated and show …
34 results